Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benitec Biopharma Inc has a consensus price target of $16 based on the ratings of 5 analysts. The high is $30 issued by Piper Sandler on June 13, 2024. The low is $4 issued by HC Wainwright & Co. on September 23, 2022. The 3 most-recent analyst ratings were released by Guggenheim, Leerink Partners, and Piper Sandler on September 12, 2024, July 22, 2024, and June 13, 2024, respectively. With an average price target of $20 between Guggenheim, Leerink Partners, and Piper Sandler, there's an implied 115.52% upside for Benitec Biopharma Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Benitec Biopharma (NASDAQ:BNTC) was reported by Guggenheim on September 12, 2024. The analyst firm set a price target for $17.00 expecting BNTC to rise to within 12 months (a possible 83.19% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Benitec Biopharma (NASDAQ:BNTC) was provided by Guggenheim, and Benitec Biopharma initiated their buy rating.
There is no last upgrade for Benitec Biopharma
There is no last downgrade for Benitec Biopharma.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Benitec Biopharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Benitec Biopharma was filed on September 12, 2024 so you should expect the next rating to be made available sometime around September 12, 2025.
While ratings are subjective and will change, the latest Benitec Biopharma (BNTC) rating was a initiated with a price target of $0.00 to $17.00. The current price Benitec Biopharma (BNTC) is trading at is $9.28, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.